Healthcare provider profile · identity verified

Mitchell Binkley, MD

Family Practice · DAVENPORT, IA · NPI 1790215994

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	613	174
Levothyroxine Sodium	Levothyroxine Sodium	451	110
Losartan Potassium	Losartan Potassium	381	108
Omeprazole	Omeprazole	352	94
Alprazolam	Alprazolam	328	65
Sertraline Hcl	Sertraline Hcl	292	68
Amlodipine Besylate	Amlodipine Besylate	273	67
Simvastatin	Simvastatin	240	63
Metoprolol Succinate	Metoprolol Succinate	224	59
Gabapentin	Gabapentin	214	62
Tamsulosin Hcl	Tamsulosin Hcl	209	56
Metformin Hcl	Metformin Hcl	183	53
Pantoprazole Sodium	Pantoprazole Sodium	178	45
Prednisone	Prednisone	171	110
Meloxicam	Meloxicam	165	47
Eliquis	Apixaban	162	34
Rosuvastatin Calcium	Rosuvastatin Calcium	147	45
Trazodone Hcl	Trazodone Hcl	145	39
Glimepiride	Glimepiride	143	37
Duloxetine Hcl	Duloxetine Hcl	141	34
Lisinopril	Lisinopril	136	37
Metoprolol Tartrate	Metoprolol Tartrate	132	31
Furosemide	Furosemide	127	34
Alendronate Sodium	Alendronate Sodium	113	32
Famotidine	Famotidine	111	23
Potassium Chloride	Potassium Chloride	110	34
Bupropion Xl	Bupropion Hcl	106	29
Albuterol Sulfate Hfa	Albuterol Sulfate	104	35
Hydrochlorothiazide	Hydrochlorothiazide	101	34
Lovastatin	Lovastatin	100	25
Atenolol	Atenolol	97	30
Venlafaxine Hcl Er	Venlafaxine Hcl	97	23
Ozempic	Semaglutide	92	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	92	29
Nifedipine Er	Nifedipine	91	23
Ezetimibe	Ezetimibe	81	21
Allopurinol	Allopurinol	77	22
Cephalexin	Cephalexin	77	50
Fluticasone Propionate	Fluticasone Propionate	77	23
Montelukast Sodium	Montelukast Sodium	76	20
Zolpidem Tartrate	Zolpidem Tartrate	75	12
Paroxetine Hcl	Paroxetine Hcl	73	16
Buspirone Hcl	Buspirone Hcl	72	17
Tramadol Hcl	Tramadol Hcl	70	12
Lorazepam	Lorazepam	68	14
Metformin Hcl Er	Metformin Hcl	68	18
Warfarin Sodium	Warfarin Sodium	67	15
Xarelto	Rivaroxaban	67	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	26
Carvedilol	Carvedilol	64	19
Jardiance	Empagliflozin	64	16
Donepezil Hcl	Donepezil Hcl	59	suppressed
Mirtazapine	Mirtazapine	58	13
Propranolol Hcl	Propranolol Hcl	58	14
Enalapril Maleate	Enalapril Maleate	54	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	15
Quetiapine Fumarate	Quetiapine Fumarate	53	suppressed
Clopidogrel	Clopidogrel Bisulfate	51	17
Escitalopram Oxalate	Escitalopram Oxalate	51	16
Pioglitazone Hcl	Pioglitazone Hcl	49	17
Sumatriptan Succinate	Sumatriptan Succinate	49	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	48	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	48	13
Amoxicillin	Amoxicillin	47	40
Amitriptyline Hcl	Amitriptyline Hcl	46	15
Azithromycin	Azithromycin	46	36
Chlorthalidone	Chlorthalidone	46	12
Clonazepam	Clonazepam	46	suppressed
Terazosin Hcl	Terazosin Hcl	46	12
Spironolactone	Spironolactone	45	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	12
Azelastine Hcl	Azelastine Hcl	40	suppressed
Irbesartan	Irbesartan	39	suppressed
Diazepam	Diazepam	37	suppressed
Primidone	Primidone	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	23
Topiramate	Topiramate	34	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Baclofen	Baclofen	31	12
Glipizide	Glipizide	31	11
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Telmisartan	Telmisartan	30	suppressed
Mometasone Furoate	Mometasone Furoate	29	suppressed
Naproxen	Naproxen	29	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Celecoxib	Celecoxib	25	12
Meclizine Hcl	Meclizine Hcl	25	11
Fosinopril Sodium	Fosinopril Sodium	24	suppressed
Lubiprostone	Lubiprostone	24	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	24	suppressed
Nabumetone	Nabumetone	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Nystatin	Nystatin	22	11
Ramipril	Ramipril	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Clindamycin Hcl	Clindamycin Hcl	20	14
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Finasteride	Finasteride	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Probenecid	Probenecid	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Invokana	Canagliflozin	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Phenobarbital	Phenobarbital	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Estradiol	Estradiol	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Temazepam	Temazepam	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Levofloxacin	Levofloxacin	13	11
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Enulose	Lactulose	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error